Low-Dose Naltrexone and Levothyroxine Interaction: What Patients and Prescribers Need to Know

Published Jan 28, 2025Updated Sep 30, 2026Last reviewed Jan 28, 2025

6 linked public sourcesEditorial, sourcing, and corrections policy

Starting low-dose naltrexone does not automatically call for a lower levothyroxine dose or a special eight-hour gap between the medicines. Keep thyroid replacement tied to thyroid-function results and maintain a consistent levothyroxine routine. The available study of 898 people with hypothyroidism found no reduction in thyroid-hormone dispensing after they started LDN. [1]

There are two separate questions: whether the medicines interfere with each other, and whether LDN changes the underlying thyroid condition. Claims that LDN routinely restores thyroid function should not be used as a reason to reduce replacement hormone.

What the thyroid study measured

A 2020 Norwegian study compared thyroid-hormone dispensing during the year before and the year after patients first received LDN. It included 898 people with prescription reimbursement codes for hypothyroidism and considered different levels of LDN exposure. [1]

Starting LDN was not associated with lower use of levothyroxine or liothyronine. Greater LDN exposure instead showed a tendency toward greater levothyroxine consumption. The researchers concluded that the results did not support claims that LDN effectively treats hypothyroidism. [1]

This was a prescription-database study, not a trial of LDN against placebo and not a measurement of thyroid-antibody changes. It directly informs the practical question of medication requirements; it does not establish that each participant's symptoms or laboratory values stayed unchanged.

For someone who feels better after starting LDN for another condition, that improvement is worth recording. It should be evaluated alongside, rather than substituted for, the thyroid tests used to set the levothyroxine dose.

Is a direct interaction listed?

The reviewed levothyroxine and oral naltrexone labels do not specify a direct interaction between the pair. Oral naltrexone labeling also states that formal interaction studies with non-opioid drugs have not been performed. [2,3]

That is a more precise description than declaring that the drugs cannot interact through any transporter, protein or metabolic pathway. The useful approach is to preserve levothyroxine's established administration routine and assess changes in symptoms or thyroid tests on their own merits.

LDN usually refers to a prescribed low-dose preparation of naltrexone. The actual strength, formulation and reason for treatment belong on the medication list. A standard-dose oral naltrexone label provides relevant pharmacology, but it is not a clinical trial of every compounded low-dose preparation.

How to schedule levothyroxine

For Synthroid tablets, the label specifies an empty stomach, 30-60 minutes before breakfast, and at least four hours from drugs known to interfere with absorption, including calcium carbonate and iron products. [2]

Those are different instructions. The breakfast interval is not a universal rule that all interacting medicines become compatible after 30 minutes.

The American Thyroid Association also describes consistent bedtime levothyroxine dosing, at least three hours after the evening meal, as an alternative to taking it 60 minutes before breakfast. [4] Use a schedule appropriate to the prescribed product and maintain it consistently.

Current routine	What matters most
Levothyroxine before breakfast, LDN later in the day	Preserve the fasting interval and the prescribed LDN schedule
Levothyroxine at bedtime	Keep the agreed interval after the evening meal
Calcium or iron supplements in the same routine	Use the levothyroxine product's separation instructions
A change in formulation, meals or medication timing	Record the change so later laboratory results can be interpreted

An eight-hour LDN gap is not a tested requirement for this pairing. The schedule should be easy enough to follow reliably, without losing track of interactions that actually affect thyroid-hormone absorption.

Monitoring: use thyroid function, not antibody trends, to set the dose

In primary hypothyroidism, levothyroxine dosing is generally adjusted using TSH together with the clinical situation. Synthroid labeling calls for checking TSH six to eight weeks after a dose change and periodic assessment once stable. [2]

Starting LDN alone does not establish a new universal testing interval. A clinician may request a follow-up result if symptoms change, thyroid treatment has recently changed, or the wider medication plan warrants it. The reason for the test should be specific.

The American Thyroid Association states that repeated thyroid-antibody measurements are not needed to monitor Hashimoto thyroiditis. Someone with high antibodies but normal TSH and free T4 does not need thyroid hormone solely because of the antibody result. Most people with established hypothyroidism from Hashimoto thyroiditis need ongoing thyroid replacement. [5]

A falling antibody number should therefore not be treated as an instruction to lower levothyroxine. If the dose changes, document the thyroid-function results and the target being pursued.

TSH targets are not identical in every thyroid condition

Central hypothyroidism and some thyroid-cancer treatment plans require a different interpretation from routine primary hypothyroidism. ATA guidance distinguishes these situations. [4] A low TSH should be reviewed against the person's diagnosis and treatment target rather than triggering an automatic dose reduction from a general article.

Similarly, thyroid replacement after surgery or radioiodine treatment should not be stopped on the assumption that LDN supplies thyroid hormone. It does not serve as a replacement hormone.

The naltrexone interaction to review separately: opioids

Naltrexone blocks opioid receptors. Standard oral labeling contraindicates use in people receiving opioid analgesics, those currently dependent on opioids and those in acute opioid withdrawal. Starting it in an opioid-dependent person can precipitate withdrawal. [3]

A low-dose prescription should not be assumed to make opioid combinations routine. Tell the prescribing team about opioid pain medicines, including intermittent use, and about any planned pain-treatment change. A loss of pain control or possible withdrawal needs prompt assessment.

The practical task is to review the actual pain regimen, not to move an opioid and naltrexone a few hours apart and assume that resolves receptor blockade. This concern is separate from levothyroxine absorption.

If new symptoms appear

Record when LDN was started or changed, the levothyroxine schedule, recent supplements and the symptom timeline. Palpitations, tremor, heat intolerance or unexplained weight loss can occur with excessive thyroid-hormone exposure, but symptoms alone do not identify the cause. [2]

Persistent symptoms warrant review and appropriate thyroid testing. Chest pain or severe symptoms should be assessed urgently. Avoid repeatedly changing both medicines at once without a clear plan, since that makes the response harder to interpret.

A useful follow-up note includes the current levothyroxine product and dose, the latest TSH/free T4 results, the reason for LDN, the actual LDN strength and the agreed next assessment. This gives the clinician something concrete to compare with the next visit.

Common questions

Will LDN let me stop levothyroxine?

The 898-person study did not demonstrate a reduction in thyroid-hormone dispensing after LDN initiation. It does not support automatically stopping or reducing thyroid replacement. [1]

Do I need a thyroid-antibody panel every time LDN changes?

Routine repeat antibody monitoring is not how ATA recommends following Hashimoto thyroiditis. Thyroid function and the clinical situation guide replacement treatment. [5]

Must LDN always be taken at bedtime?

Use the schedule on the prescription. Bedtime is not a levothyroxine-specific requirement, and an assumed nightly immune "rebound" should not dictate thyroid-hormone adjustments.

Should I move levothyroxine if I start LDN?

A stable, effective thyroid routine should not be changed solely to create an arbitrary gap. Review the complete schedule, especially meals and known absorption-interfering products.